ImmunoCellular Therapeutics Ltd | D: Filing D
Sep 12, 2022 16:02 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S
Jun 8, 2018 16:07 ET
EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.1%),Daniel B. Asher(1.1%), etc.
Feb 13, 2018 06:31 ET
EOM Pharmaceutical Holdings | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(0.38%),Ryan M. Lane(0.38%), etc.
Jan 16, 2018 12:47 ET
EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals
Jul 31, 2017 06:06 ET
EOM Pharmaceutical Holdings | SC 13G: Statement of acquisition of beneficial ownership by individuals-Empery Asset Management, LP(9.99%),Ryan M. Lane(9.99%), etc.
Jul 19, 2017 12:07 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Gengos Andrew
Feb 13, 2017 16:04 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Yu John S
Jun 21, 2016 16:35 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Officer Titus Gary
Jun 21, 2016 16:34 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director Singhvi Rahul
Jun 21, 2016 16:34 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director SCHLOSSBERG MARK A
Jun 21, 2016 16:33 ET
EOM Pharmaceutical Holdings | 4: Statement of changes in beneficial ownership of securities-Director LAPOINTE ANTHONY GREGG
Jun 21, 2016 16:32 ET
No Data
No Data